Articles

Psychiatric Comorbidity and Quality of Life in Patients with Dermatologic Diseases

Abstract

Objective: The aim of this study was to evaluate the prevalence ofpsychiatric disorders in patients with dermatologic disease and its relationship to the patients' quality of life.
Method:
This study was cross-sectional. A total of 414 patients with various dermatologic diseases participated in this study. The participants were recruited from an outpatient clinic and inpatient ward of a referral dermatologic hospital using a simple random sampling method. Demographic variables, duration and characteristics of disease and admission status were recorded. Patients were asked to complete two questionnaires: GHQ-28 (General Health Questionnaire) ,and DLQI (Dermatologic Life Quality Index).
Results:
The estimated prevalence of psychiatric comorbidity in dermatologic patients was %51.3.There was a significant relationship between GHQ score and educational level, marriage statues, type and course of dermatologic disease and admission status (p<0.05). The probability of psychiatric disorders increased among patients with lower educational level, married subjects, patients with relapse of the disease and those having some special skin diseases such as Psoriasis and Pemphigus. However, no significant relationship was observed between the GHQ score and duration of disease and sex. Moreover, there was a significant relationship between quality of life and educational level, marriage status, type of dermatologic disease, course of disease and admission status (p<0.05). Higher quality of life was observed among participants with higher educational level, those who were unmarried, patients with first episode and milder diseases. This study shows a significant relationship between quality of life and mental health (p<0.05). The lower probability of concomitant mental disorder, the higher the quality of life.
Conclusion: Psychiatric disorders are frequent among patients with dermatologic diseases. These disorders have a negative effect on quality of life. Psychiatric consultation, liaison services and education in dermatologic wards can help the diagnosis, treatment and follow up of psychiatric comorbidity in dermatologic patients.

Kimball AB, Jacobson C, Weiss S, Vreeland MG, Wu Y. The Psychosocial Burden of Psoriasis. Am J Clin Dermatol 2005;6 :383-392.

Schultz HY. Society for Investigative Dermatology Skin Disease Comorbidities Project Launch Conference Proceedings. J Invest Dermatol 2009; 129: 525–528.

Gupta MA. Psychiatric comorbidity in dermatologic disorders. In: walker C , papadoulos L, eds. Psychodermatology. Cambridge: Cambridge University Press; 2005 .

4.Picardi A, Abeni D, Melchi CF,Puddu P,Pasquini P. Psychiatric morbidity in dermatological outpatient: an issue to be recognized. Br j Dermatol 2000; 143: 983-991.

5.Mechri A, Amri M, Douarika AA, Ali Hichem BH, Zouari B, Zili J. Psychiatric morbidity and quality of life in Vitiligo: a case controlled study. Tunis Med 2006 ; 84:632-635.

Akay A, Pekcanlar A, Bozdag KE, Altintas L, Karaman A. Assessment of depression in subjects with psoriasis vulgaris and lichen planus. J Eur Acad Dermatol Venereol 2002 ;16:347-352.

Leekassa R, Bizuneh E, Alem A. Prevalence of mental distress in the outpatient clinic of a specialized leprosy hospital. Addis Ababa, Ethiopia, 2002. Lepr Rev 2004; 75:367-375.

Aktan S, Ozmen E, Sanli B. Psychiatric disorders in patients attending a dermatology outpatient clinic . Dermatology 1998;197:230-234.

Noorbala AA, Mohammad K, Bagheri Yazdi SA. [Validation of GHQ-28 in Iran]. Hakim 1999 ;5:101- 110.

Aghaei S, Sodaifi M, Jafari P, Mazharinia N, Finlay AY. DLQI scores in vitiligo: reliability and validity of the Persian version. BMC Dermatol 2004 ; 4 : 8.

Mohammadi MR, Davidian H, Noorbala AA, Malekafzali H, Naghavi HR, Pouretemad HR ,etal. An epidemiological survey of psychiatric disorders in Iran. Clin Pract Epidemol Ment Health 2005 ; 1:16.

Hughes JE, Barraclough BM, Hamblin LG, White JE. Psychiatric symptoms in dermatology patients. Br J Psychiatry 1983; 143: 51-54.

Carney O, Ross E, Bunker C, Ikkos G, Mindel A. A prospective study of the psychological impact on patients with a first episode of genital herpes. Genitourin Med 1994; 70: 40-45.

Wessely SC, Lewis GH. The classification of psychiatric morbidity in attenders at a dermatology clinic. Br J Psychiatry 1989; 155: 686-691.

Gupta MA, Gupta AK. Age and gender differences in the impact of psoriasis on quality of life. Int j dermatol 1995; 34; 700-703.

Files
IssueVol 4 No 3 (2009) QRcode
SectionArticles
Keywords
Comorbidity Mental disorders Quality of life Skin Diseases

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Ghaninejad H, Samadi Z, Zhand N, Arbabi M, Golestan B. Psychiatric Comorbidity and Quality of Life in Patients with Dermatologic Diseases. Iran J Psychiatry. 1;4(3):102-106.